Effect of Propranolol Alone and in Combination with Pyrimethamine on Acute Murine Toxoplasmosis

Jundishapur Journal of Microbiology

Volumn 8, Issue 9, 2015, Pages

  Montazeri, Mahbobeh ^a,b   Daryani, Ahmad ^a,b   Ebrahimzadeh, Mohammadali ^c   Ahmadpour, Ehsan ^d   Sharif, Mehdi ^a,b   Sarvi, Shahabeddin ^a,b  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Mice; Propranolol; Pyrimethamine; Toxoplasma

Indexed keywords

EID: 84978230841     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.22572     Document Type: Article

References (23)

1. Petersen E. Toxoplasmosis. Semin Fetal Neonatal Med. 2007;12(3):214–23.
2. Weiss LM, Dubey JP. Toxoplasmosis: A history of clinical observa-tions. Int J Parasitol. 2009;39(8):895–901.
3. Weiss LM, Kim K. Toxoplasma gondii: the model apicomplexan. Per-spectives and methods. Academic Press; 2011.
4. Ambroise-Thomas P, Pelloux H. Toxoplasmosis-congenital and in immunocompromised patients: a parallel. Parasitol Today. 1993;9(2):61–3.
5. Serranti D, Buonsenso D, Valentini P. [Congenital toxoplasmosis treatment]. Eur Rev Med Pharmacol Sci. 2011;15(2):193–8.
6. Al-Zanbagi NA. Effectiveness of Myrrh and Spiramycin as Inhibi-tors for Toxoplasma gondii Tachyzoites in vivo. Mansoura J Foren-sic Med Clin Toxicol. 2007;15(2):117–28.
7. Araujo FG, Remington JS. Recent advances in the search for new drugs for treatment of toxoplasmosis. Int J Antimicrob Agents. 1992;1(4):153–64.
8. Ryning FW, Remington JS. Effect of cytochalasin D on Toxoplas-ma gondii cell entry. Infect Immun. 1978;20(3):739–43.
9. Morisaki JH, Heuser JE, Sibley LD. Invasion of Toxoplasma gondii occurs by active penetration of the host cell. J Cell Sci. 1995;108 (Pt 6):2457–64.
10. D'Angelo JG, Bordon C, Posner GH, Yolken R, Jones-Brando L. Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle. J Antimicrob Chemother. 2009;63(1):146–50.
11. Daryani A, Ebrahimzadeh MA, Sharif M, Rezaei F, Ahmadpour E, Sarvi S. The inhibitory effect of ketotifen on entrance of Toxo-plasma gondii tachyzoites into macrophages of mouse. J Mazan-daran Univ Med Sci. 2014;23(110):75–80.
12. Daryani A, Hosseini AZ, Dalimi A. Immune responses against excreted/secreted antigens of Toxoplasma gondii tachyzoites in the murine model. Vet Parasitol. 2003;113(2):123–34.
13. Yang CD, Chang GN, Chao D. Protective immunity against Toxo-plasma gondii in mice induced by the SAG2 internal image of anti-idiotype antibody. Parasitol Res. 2003;91(6):452–7.
14. Dadimoghaddam Y, Daryani A, Sharif M, Ahmadpour E, Hossie-nikhah Z. Tissue tropism and parasite burden of Toxoplasma gondii RH strain in experimentally infected mice. Asian Pac J Trop Med. 2014;7(7):521–4.
15. Langslet A. Membrane stabilization and cardiac effects of d,1-propranolol, d-propranolol and chlorpromazine. Eur J Pharma-col. 1970;13(1):6–14.
16. Martins-Duarte ES, de Souza W, Vommaro RC. Toxoplasma gon-dii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model. Exp Parasitol. 2013;133(3):294–9.
17. Fung HB, Kirschenbaum HL. Treatment regimens for patients with toxoplasmic encephalitis. Clin Ther. 1996;18(6):1037–56.
18. Foppa CU, Bini T, Gregis G, Lazzarin A, Esposito R, Moroni M. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimeth-amine. Eur J Clin Microbiol Infect Dis. 1991;10(3):187–9.
19. Ohnishi ST, Sadanaga KK, Katsuoka M, Weidanz WP. Effects of membrane acting-drugs on plasmodium species and sickle cell erythrocytes. Mol Cell Biochem. 1989;91(1-2):159–65.
20. Singh N, Puri SK. Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis. Acta Trop. 2000;77(2):185–93.
21. Murphy SC, Harrison T, Hamm HE, Lomasney JW, Mohandas N, Haldar K. Erythrocyte G protein as a novel target for malarial che-motherapy. PLoS Med. 2006;3(12):e528.
22. Manninen V. Movements of sodium and potassium ions and their tracers in propranolol-treated red cells and diaphragm muscle. Acta Physiol Scand Suppl. 1970;355:1–76.
23. Porter RS, Kaplan JL. The Merck manual of diagnosis and therapy. 18th ed. Rahway, New Jersey: Merck Research Laboratories;